Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Irm Llc
Irm Llc A Delaware Limited Liability Company
Irm Llc_20100121
Irm Llc_20100128
Irm Llc_20131212
  

Irm Llc patents

Recent patent applications related to Irm Llc. Irm Llc is listed as an Agent/Assignee. Note: Irm Llc may have other listings under different names/spellings. We're not affiliated with Irm Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Irm Llc-related inventors




Date Irm Llc patents (updated weekly) - BOOKMARK this page
05/18/17Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
06/23/16New screening the treatment friedreich's ataxia
06/16/16Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
02/25/16Methods of treating fgf21-associated disorders
07/16/15Compounds and compositions for modulating egfr activity
06/25/15Compounds and compositions for the treatment of parasitic diseases
05/07/15Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation status
04/16/15Site-specific labeling methods and molecules produced thereby
02/19/15Compounds and compositions as c-kit kinase inhibitors
01/08/15Compounds and compositions for the treatment of parasitic diseases
01/01/15Lectin-like oxidized ldl receptor 1 antibodies and methods of use
10/30/14Compounds and compositions as tlr2 agonists
10/09/14Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
09/18/14Compounds and compositions for the treatment of parasitic diseases
09/18/14Compounds and compositions for the treatment of parasitic diseases
09/18/14Compounds and compositions for the treatment of parasitic diseases
08/14/14Compounds and compositions as c-kit kinase inhibitors
07/24/14Compounds and compositions as pdgfr kinase inhibitors
06/05/14Compounds and compositions for the treatment of parasitic diseases
04/24/14Compounds that expand hematopoietic stem cells
01/30/14Compounds and compositions as c-kit kinase inhibitors
01/09/14Compounds and compositions as protein kinase inhibitors
12/26/13Compounds and compositions as lxr modulators
12/12/13Compounds and compositions as trk inhibitors
11/28/13Pcsk9 antagonists
11/21/13N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/07/13Methods of using alk inhibitors
10/03/13Compositions and methods for modulating farnesoid x receptors
08/15/13Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
08/15/13Methods and compositions for treating cancers
06/20/13Mechanically-activated cation channels
05/16/13Benzonapthyridine compositions and uses thereof
04/18/13Compounds and methods for modulating g protein-coupled receptors
03/07/13Compounds and compositions as c-kit kinase inhibitors
01/03/13Compounds and compositions as protein kinase inhibitors
09/06/12Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
08/23/12Compounds and compositions as lxr modulators
08/09/12Compounds and compositions as itpkb inhibitors
08/02/12Compounds and compositions as modulators of gpr119 activity
08/02/12Compounds and compositions as hedgehog pathway modulators
07/12/12Mesenchymal stem cell differentiation
03/15/12Compounds and compositions as trk inhibitors
02/02/12Methods and compositions for treating allergic diseases
12/15/11Compounds and compositions as protein kinase inhibitors
10/27/11Compounds and compositions as modulators of gpr119 activity
10/27/11Compounds and compositions as itpkb inhibitors
10/20/11Compounds and compositions as channel activating protease inhibitors
10/20/11Compounds and compositions as protein kinase inhibitors
10/20/11Compounds and compositions as protein kinase inhibitors
10/06/11Compounds and compositions as modulators of gpr119 activity
09/29/11N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
08/04/11Compounds and compositions as protein kinase inhibitors
08/04/11Compounds and compositions as modulators of gpr119 activity
08/04/11Compounds and compositions as kinase inhibitors
08/04/114-phenoxymethylpiperidines as modulators of gpr119 activity
07/28/11Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
07/21/11Compounds and compositions as channel activating protease inhibitors
07/14/11Compounds and compositions as modulators of gpr119 activity
07/14/11Compounds and methods for modulating g protein-coupled receptors
07/07/11Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
07/07/11Compounds and compositions as modulators of gpr119 activity
06/30/11Antagonists of protease activated receptor-1 (par1)
06/23/11Hedgehog pathway modulators
04/28/11Anti-trkb antibodies
04/28/112,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
Patent Packs
03/10/11Compounds and compositions useful for the treatment of parasitic diseases
03/03/11Compounds and compositions as syk kinase inhibitors
03/03/11Protein kinase inhibitors and methods for using thereof
03/03/112-heteroarylamino-pyrimidine derivatives as kinase inhibitors
02/24/11Methods and compositions for treating lymphoma and myeloma
01/27/11Compositions and methods for treating cancers
01/06/11Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors
01/06/11Compounds and compositions as kinase inhibitors
12/30/10Antagonist antibodies of protease activated receptor-1 (par1)
12/23/10Compounds and compositions as protein kinase inhibitors
11/25/102-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
09/23/10Compounds and compositions as channel activating protease inhibitors
09/16/10Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
08/12/10Inhibitors of cathepsin s
08/05/10Biphenylcarboxamide derivatives as hedgehod pathway modulators
Patent Packs
07/29/10Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
07/22/10Compounds that expand hematopoietic stem cells
07/22/10Compounds and compositions as itpkb inhibitors
07/22/10Protein kinase inhibitors and methods for using thereof
07/22/10Compounds and compositions as c-kit and pdgfr kinase inhibitors
07/01/10Compounds and compositions as kinase inhibitors
06/17/10Agonist trkb antibodies and uses thereof
05/13/10Compounds and compositions as modulators of gpr119 activity
04/08/10Protein kinase inhibitors and methods for using thereof
04/01/10Compositions and methods for modulating c-kit and pdgfr receptors
03/04/10Compounds and compositions as channel activating protease inhibitors
02/25/10Oxazole and thiazole ppar modulator
02/25/10Compounds and compositions as protein kinase inhbitors
02/18/10Methods for identifying compounds that inhibit hiv infection
02/11/10Compounds and methods for modulating g protein-coupled receptors
01/28/10Compounds and compositions as modulators of gpr119 activity
01/28/10Thiazole derivatives as modulators of g protein-coupled receptors
01/21/10Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
12/31/09Compounds and compositions as lxr modulators
12/17/09Compounds and compositions as hedgehog signaling pathway modulators
12/17/09Compositions and methods for fgf receptor kinases inhibitors
12/03/09Compounds and compositions as modulators of steroidal receptors and calcium channel activities
10/29/09Compounds and compositions as modulators of gpr119 activity
10/15/09Compounds and compositions as protein kinase inhibitors
10/08/09Methods and compositions for inhibiting hiv infection
10/01/09Azolopyrimidines as inhibitors of cannabinoid 1 activity
09/03/09Immunosuppressant compounds and compositions
08/13/09Compounds and compositions as hedgehog pathway modulators
07/30/09Compounds and compositions as ppar modulators
07/16/09Compounds and compositions as protein kinase inhibitors
Social Network Patent Pack
06/18/09Methods and compositions for modulating foxo1 activity and insulin signaling
06/04/09Screening assay to identify modulators of the sleep/wake cycle
05/28/09Compounds and compositions as protein kinase inhibitors
05/28/09Inhibitors of cathepsin s
05/28/09Compounds and compositions as ppar modulators
05/28/09Spiro imidozole derivatives as ppar modulators
05/21/09Immunosuppressant compounds and compositions
04/23/09Compounds and compositions as protein kinase inhibitors
04/02/09Compositions comprising them as ppar modulators
03/19/09Methods and compositions for treating allergic diseases
Patent Packs
03/19/09Heterotetracyclic compounds as tpo mimetics
03/12/09Compounds and compositions as protein kinase inhibitors
02/26/09Compounds and compositions as modulators of steroid hormone nuclear receptors
12/12/13Compounds and compositions as trk inhibitors
01/28/10Thiazole derivatives as modulators of g protein-coupled receptors
01/21/10Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
07/16/15Compounds and compositions for modulating egfr activity
06/04/15Compounds and compositions for modulating egfr activity
04/16/15Compounds and compositions as protein kinase inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Irm Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Irm Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';